Nathan Furstoss

发表

ATP-competitive Plk1 inhibitors induce caspase 3-mediated Plk1 cleavage and activation in hematopoietic cell lines

G. Pagès, G. Robert, P. Auberger, 2017, Oncotarget.

IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential

G. Robert, P. Auberger, F. Luciano, 2018, Scientific Reports.

LAMP2 expression dictates azacytidine response and prognosis in MDS/AML

N. Mounier, J. Tamburini, G. Robert, 2019, Leukemia.

Reprogramming monocyte-derived macrophages through caspase inhibition

M. Arcangeli, E. Solary, G. Robert, 2021, Oncoimmunology.

In Vitro and in Vivo Evaluation of Fully Substituted (5-(3-Ethoxy-3-oxopropynyl)-4-(ethoxycarbonyl)-1,2,3-triazolyl-glycosides as Original Nucleoside Analogues to Circumvent Resistance in Myeloid Malignancies.

G. Robert, P. Auberger, R. Benhida, 2017, Journal of medicinal chemistry.

Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma

P. Abbe, G. Robert, P. Auberger, 2021, Cancer Research.

Acadesine Circumvents Azacitidine Resistance in Myelodysplastic Syndrome and Acute Myeloid Leukemia

A. Stamatoullas, P. Rohrlich, N. Mounier, 2019, International Journal of Molecular Sciences.

IL-34 and CSF-1 display an equivalent macrophage differentiation ability but a different polarization potential

G. Robert, P. Auberger, F. Luciano, 2018, Scientific Reports.

Differentiation inducing factor 3 mediates its anti-leukemic effect through ROS-dependent DRP1-mediated mitochondrial fission and induction of caspase-independent cell death

G. Robert, P. Auberger, T. Cluzeau, 2016, Oncotarget.